- Home
- EFSC vs SLNO Comparison
EFSC vs SLNO Comparison
Compare EFSC & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSC
- SLNO
- Stock Information
- Founded
- EFSC 1988
- SLNO 1999
- Country
- EFSC United States
- SLNO United States
- Employees
- EFSC N/A
- SLNO N/A
- Industry
- EFSC Major Banks
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EFSC Finance
- SLNO Health Care
- Exchange
- EFSC Nasdaq
- SLNO Nasdaq
- Market Cap
- EFSC 2.0B
- SLNO 3.8B
- IPO Year
- EFSC 1999
- SLNO 2014
- Fundamental
- Price
- EFSC $57.36
- SLNO $82.27
- Analyst Decision
- EFSC Strong Buy
- SLNO Strong Buy
- Analyst Count
- EFSC 3
- SLNO 9
- Target Price
- EFSC $64.33
- SLNO $105.11
- AVG Volume (30 Days)
- EFSC 207.4K
- SLNO 1.4M
- Earning Date
- EFSC 07-28-2025
- SLNO 08-06-2025
- Dividend Yield
- EFSC 2.10%
- SLNO N/A
- EPS Growth
- EFSC 9.23
- SLNO N/A
- EPS
- EFSC 5.09
- SLNO N/A
- Revenue
- EFSC $619,222,000.00
- SLNO N/A
- Revenue This Year
- EFSC $14.06
- SLNO N/A
- Revenue Next Year
- EFSC $4.85
- SLNO N/A
- P/E Ratio
- EFSC $11.25
- SLNO N/A
- Revenue Growth
- EFSC 6.50
- SLNO N/A
- 52 Week Low
- EFSC $39.47
- SLNO $41.50
- 52 Week High
- EFSC $63.13
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- EFSC 65.09
- SLNO 51.33
- Support Level
- EFSC $56.49
- SLNO $79.70
- Resistance Level
- EFSC $58.17
- SLNO $90.32
- Average True Range (ATR)
- EFSC 1.14
- SLNO 3.66
- MACD
- EFSC 0.23
- SLNO -0.41
- Stochastic Oscillator
- EFSC 85.38
- SLNO 31.42
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.